🔗 Permalink

Inventor profile of:

Philip D. Gregory

City:

Richmond, California

Country:

United States

Published Applications:

Last publication date:

2019-06-06

Top Assignees for applications by Philip D. Gregory

The entities that hold a legal rights for patent applications filed by inventor Gregory Philip D.:

Sangamo Therapeutics, Inc. 16 Richmond, CA United States
SANGAMO BIOSCIENCES, INC. 11 Richmond, CA United States
Ospedale San Raffaele S.R.L. 5 Milan, Italy
Sangamo Therapeutics, Inc. 5 Brisbane, CA United States
Board of Regents, The University of Texas System 1 Austin, TX United States
Fondazione Telethon 1 Rome, Italy
Sangamo BioScience, Inc. 1 Richmond, CA United States
The Children's Hospital of Philadelphia 1 Philadelphia, PA United States
University of Southern California 1 Los Angeles, CA United States
BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEMS 1 Austin, TX United States

Recent patent applications by Gregory Philip D.

Philip D. Gregory from Richmond, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2019-06-06

US20190169640A1

Chemistry; metallurgy

DNA-binding proteins and uses thereof

#2 | 2019-02-14

US20190046579A1

Human necessities

Targeted disruption of T cell receptor genes using engineered zinc finger protein nucleases

#3 | 2018-11-15

US20180326000A1

Human necessities

Methods and compositions for modulating PD1

#4 | 2018-11-08

US20180319864A1

Chemistry; metallurgy

Methods and compositions for modification of a HLA locus

#5 | 2018-08-09

US20180223311A1

Chemistry; metallurgy

Methods and compositions for treatment of a genetic condition

#6 | 2018-08-02

US20180214485A1

Human necessities

Targeted disruption of T cell receptor genes using engineered zinc finger protein nucleases

#7 | 2018-07-19

US20180201955A1

Chemistry; metallurgy

Targeted integration into the PPP1R12C locus

#8 | 2018-07-19

US20180200332A1

Human necessities

Methods and compositions for treating trinucleotide repeat disorders

#9 | 2018-01-11

US20180010152A1

Chemistry; metallurgy

DNA-binding proteins and uses thereof

#10 | 2017-08-03

US20170216358A1

Human necessities

METHODS AND COMPOSITIONS FOR MODIFICATION OF HLA

#11 | 2017-06-29

US20170183420A1

Chemistry; metallurgy

T cell modifying compounds and uses thereof

#12 | 2017-01-19

US20170016030A1

Chemistry; metallurgy

DNA-binding proteins and uses thereof

#13 | 2016-10-06

US20160289699A1

Chemistry; metallurgy

Targeted integration into the PPP1R12C locus

#14 | 2016-08-18

US20160237457A1

Chemistry; metallurgy

Linear donor constructs for targeted integration

#15 | 2016-08-04

US20160220634A1

Human necessities

Methods and compositions for modulating PD1

#16 | 2016-01-28

US20160024474A1

Chemistry; metallurgy

Methods and compositions for modulating nuclease-mediated genome engineering in hematopoietic stem cells

#17 | 2016-01-28

US20160022737A1

Human necessities

Gene editing for HIV gene therapy

#18 | 2015-11-19

US20150329875A1

Chemistry; metallurgy

Methods and compositions for prevention or treatment of a disease

#19 | 2015-09-24

US20150267223A1

Chemistry; metallurgy

METHODS AND COMPOSITIONS FOR REGULATING HIV INFECTION

#20 | 2015-09-24

US20150267205A1

Chemistry; metallurgy

Methods and compositions for regulation of zinc finger protein expression

#21 | 2015-09-10

US20150252094A1

Chemistry; metallurgy

Methods and compositions for modification of a HLA locus

#22 | 2015-08-13

US20150225727A1

Chemistry; metallurgy

Linear donor constructs for targeted integration

#23 | 2015-06-25

US20150174169A1

Human necessities

Delivery methods and compositions for nuclease-mediated genome engineering in hematopoietic stem cells

#24 | 2015-06-18

US20150164954A1

Human necessities

Targeted disruption of T cell receptor genes using engineered zinc finger protein nucleases

#25 | 2015-02-05

US20150037304A1

Human necessities

METHODS AND COMPOSITIONS FOR MODIFICATION OF HLA

#26 | 2014-11-27

US20140349394A1

Chemistry; metallurgy

Targeted integration into the PPP1R12C locus

#27 | 2014-10-09

US20140301990A1

Human necessities

Targeted disruption of T cell receptor genes using talens

#28 | 2014-06-05

US20140155468A1

Chemistry; metallurgy

Isolated mouse or human cell having an exogenous transgene in an endogenous albumin gene

#29 | 2014-05-15

US20140134741A1

Chemistry; metallurgy

DNA-binding proteins and uses thereof

#30 | 2014-05-15

US20140134740A1

Chemistry; metallurgy

DNA-binding proteins and uses thereof

#31 | 2014-05-15

US20140134723A1

Chemistry; metallurgy

DNA-binding proteins and uses thereof

#32 | 2014-05-01

US20140120622A1

Chemistry; metallurgy

T cell modifying compounds and uses thereof

#33 | 2014-04-03

US20140093913A1

Chemistry; metallurgy

Methods and compositions for treatment of a genetic condition

#34 | 2014-03-20

US20140080216A1

Chemistry; metallurgy

Methods and compositions for treatment of a genetic condition

#35 | 2014-01-30

US20140030240A1

Human necessities

Methods and compositions for modulating PD1

#36 | 2013-09-19

US20130244332A1

Chemistry; metallurgy

Targeted integration and expression on exogenous nucleic acid sequences

InventorID:

444702 ⎘